GenVec (GNVC) Reports Dosing in Novartis (NVS) Phase 1/2 Using Bilateral Hearing Loss Treatment Tech
Tweet Send to a Friend
On October 28, 2014, GenVec (Nasdaq: GNVC) became aware that the first patient was dosed earlier that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
